<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84">





	<url>
		<loc>http://www.evocutis.com/news/view/74/evocutis-validates-anti-ageing-labskin-model</loc>
		<lastmod>2012-01-27T11:52:30+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/73/results-of-2012-evocutis-agm</loc>
		<lastmod>2012-01-24T15:05:00+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/72/evocutis-opens-state-of-the-art-skin-histology-laboratory-facilities</loc>
		<lastmod>2012-01-13T10:16:07+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/70/directors-dealing</loc>
		<lastmod>2011-12-23T10:19:58+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/69/dr-richard-bojar-evocutis-chief-scientific-officer-interviewed-about-labskintm-at-microbiota-paris</loc>
		<lastmod>2011-12-21T16:04:37+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/68/notice-of-agm-and-report-and-accounts</loc>
		<lastmod>2011-12-15T10:37:12+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/67/evocutis-announces-preliminary-results-for-the-year-ended-31-july-2011</loc>
		<lastmod>2012-01-10T11:10:05+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/66/evocutis-launches-in-vitro-antimicrobial-and-prebiotic-assays-using-labskin</loc>
		<lastmod>2011-11-28T11:35:54+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/65/ticker-change-syntopix-syn-changes-to-evocutis-evo</loc>
		<lastmod>2011-10-25T17:26:46+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/64/result-of-general-meeting-on-20th-october-2011-and-change-of-name-to-evocutis-plc</loc>
		<lastmod>2011-10-24T12:36:42+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/63/</loc>
		<lastmod>2011-09-30T11:25:21+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/62/</loc>
		<lastmod>2011-09-27T09:42:27+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/8/</loc>
		<lastmod>2011-09-15T16:40:00+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/3/syntopix-announce-change-of-registered-office</loc>
		<lastmod>2011-10-17T16:44:43+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/4/syntopix-directorate-change</loc>
		<lastmod>2011-10-17T16:29:37+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/6/result-of-2011-syntopix-general-meeting</loc>
		<lastmod>2011-09-15T16:34:26+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/37/syntopix-acquisition-and-placing-to-raise-2-million</loc>
		<lastmod>2011-09-22T16:13:47+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/38/syntopix-business-update</loc>
		<lastmod>2011-09-22T16:38:57+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/39/syntopix-interim-results</loc>
		<lastmod>2011-09-22T17:07:59+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/40/holdings-in-company</loc>
		<lastmod>2011-09-27T14:38:54+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/41/holdings-in-company</loc>
		<lastmod>2011-09-27T14:36:33+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/42/result-of-syntopix-agm</loc>
		<lastmod>2011-09-22T17:11:42+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/43/syntopix-to-research-biofilms-for-beiersdorf-ag</loc>
		<lastmod>2011-09-22T17:12:59+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/44/syntopix-annual-report-and-notice-of-agm</loc>
		<lastmod>2011-09-22T17:15:22+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/45/grant-of-share-options-to-directors</loc>
		<lastmod>2011-09-22T17:18:02+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/46/syntopix-final-results</loc>
		<lastmod>2011-09-22T17:25:37+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/47/appointment-of-broker</loc>
		<lastmod>2011-09-22T17:26:36+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/48/second-agreement-with-sinclair-pharma</loc>
		<lastmod>2011-09-22T17:29:43+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/49/holdings-in-company</loc>
		<lastmod>2011-09-27T14:23:17+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/50/holdings-in-company</loc>
		<lastmod>2011-09-27T14:34:13+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/51/agreement-with-global-consumer-products-company</loc>
		<lastmod>2011-09-22T17:31:23+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/52/syntopix-directorate-change</loc>
		<lastmod>2011-09-22T17:34:31+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/53/agreement-with-sinclair-pharma-plc</loc>
		<lastmod>2011-09-22T17:35:59+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/54/result-of-syntopix-general-meeting</loc>
		<lastmod>2011-09-22T17:37:37+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/55/proposed-fundraising</loc>
		<lastmod>2011-09-22T17:41:49+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/56/syntopix-interim-results</loc>
		<lastmod>2011-09-22T17:43:31+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/57/directorate-change</loc>
		<lastmod>2011-09-22T17:45:20+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/58/result-of-agm</loc>
		<lastmod>2011-09-22T17:47:09+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/news/view/7/result-of-agm-2010</loc>
		<lastmod>2011-09-15T16:43:16+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>





	<url>
		<loc>http://www.evocutis.com/blog/view/9/speeding-up-the-transition-to-greener-surfactants</loc>
		<lastmod>2011-09-29T16:35:07+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/10/the-future-of-innovation-in-biocides</loc>
		<lastmod>2011-09-29T16:41:20+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/11/skin-bacteria-and-mobile-and-lsquophones-making-the-right-call</loc>
		<lastmod>2011-09-29T16:41:55+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/12/formulation-guided-by-hansen-solubility-parameters-and-realized-via-high-throughput-screening</loc>
		<lastmod>2011-10-13T15:35:09+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/13/the-fda-otc-acne-monograph-and-ndash-stifling-the-development-of-better-treatments</loc>
		<lastmod>2011-09-28T10:37:46+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/14/syntopix-to-present-tbhq-data-at-icaac-2010</loc>
		<lastmod>2011-09-27T16:33:29+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/15/finding-a-partner-for-your-great-idea-how-do-your-get-their-attention</loc>
		<lastmod>2011-09-27T16:09:34+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/16/is-skin-a-poor-polymer</loc>
		<lastmod>2011-09-27T16:33:52+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/17/on-the-scent-trail-deodorant-specificity</loc>
		<lastmod>2011-09-27T16:10:36+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/18/if-you-and-rsquore-not-living-on-the-edge-and-hellip</loc>
		<lastmod>2011-09-27T16:11:44+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/19/the-alchemists-and-rsquo-assistant</loc>
		<lastmod>2011-09-27T16:12:57+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/20/do-r-and-d-cuts-really-mean-in-licence-boom</loc>
		<lastmod>2011-09-27T16:13:29+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/21/resveratrol-exciting-anti-acne</loc>
		<lastmod>2011-09-27T16:15:13+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/22/acne-deficit-of-cd14-mononuclear-cells-leaves-inflammation-unchecked</loc>
		<lastmod>2011-09-27T16:15:46+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/23/european-dermatologists-are-told-to-steer-clear-of-topical-antibiotics</loc>
		<lastmod>2011-09-27T16:17:22+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/24/antimicrobial-activity-of-2-tert-butylhydroquinone-tbhq-and-bismuth-or-copper-new-synergistic-combinations-for-the-treatment-of-acne</loc>
		<lastmod>2011-09-27T16:18:30+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/25/tbhq-represents-a-new-class-of-antibacterial-for-topical-applications-in-dermatology</loc>
		<lastmod>2011-09-27T16:19:44+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/26/heme-oxygenase-1-an-overlooked-potential-target-in-inflammatory-skin-disease</loc>
		<lastmod>2011-09-27T16:20:52+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/27/the-search-for-p.-acnes-inhibitors</loc>
		<lastmod>2011-09-27T16:23:10+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/28/misleading-cosmetic-claims-have-we-reached-a-turning-point</loc>
		<lastmod>2011-09-27T16:25:38+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/29/rapid-clinical-evaluation-of-topical-anti-acne-formulations-more-speed-less-haste</loc>
		<lastmod>2011-09-27T16:27:49+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/30/natural-preservatives</loc>
		<lastmod>2011-09-27T16:28:41+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/31/artificial-sebum-finding-the-right-recipe</loc>
		<lastmod>2011-09-27T16:29:33+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/32/p.-acnes-biofilms-and-ndash-where-is-the-evidence-that-they-are-important-in-skin-colonisation-or-acne</loc>
		<lastmod>2011-09-27T16:30:34+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


	<url>
		<loc>http://www.evocutis.com/blog/view/33/formulating-the-right-effect</loc>
		<lastmod>2011-09-27T16:32:25+00:00</lastmod>
		<priority>0.5</priority>
		<changefreq>weekly</changefreq>		
	</url>


<url>
<loc>http://www.evocutis.com/home/</loc>
<lastmod>2012-01-13T10:23:31+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/</loc>
<lastmod>2011-10-13T17:07:56+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/</loc>
<lastmod>2011-10-20T15:32:48+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/technologies/</loc>
<lastmod>2011-10-20T15:35:47+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/</loc>
<lastmod>2011-10-24T16:10:46+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/</loc>
<lastmod>2011-10-20T15:41:39+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/downloads/</loc>
<lastmod>2011-10-20T12:02:26+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/contact/</loc>
<lastmod>2011-10-24T19:41:06+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/microbiology/antimicrobial-database/</loc>
<lastmod>2011-10-24T14:26:43+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/investment-overview/business-strategy/</loc>
<lastmod>2011-10-14T17:35:32+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/who-we-are/vision/</loc>
<lastmod>2011-10-14T15:16:50+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/who-we-are/</loc>
<lastmod>2011-10-20T10:52:14+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/what-we-do/</loc>
<lastmod>2011-10-20T15:30:24+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/investment-overview/competitive-difference/</loc>
<lastmod>2011-10-20T15:43:25+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/who-we-are/people/</loc>
<lastmod>2012-01-18T10:24:18+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/strategy/</loc>
<lastmod>2011-10-14T15:38:18+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/investment-overview/company-factsheet/</loc>
<lastmod>2011-10-20T16:10:13+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/who-we-are/background/</loc>
<lastmod>2011-10-13T15:11:53+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/who-we-are/careers/</loc>
<lastmod>2012-02-10T15:48:16+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/difference/</loc>
<lastmod>2011-10-14T15:15:40+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/business-development/</loc>
<lastmod>2011-10-19T22:47:58+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/who-we-are/location/</loc>
<lastmod>2011-10-24T14:22:14+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/shares/share-price-info/</loc>
<lastmod>2011-10-25T17:18:06+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/microbiology/</loc>
<lastmod>2011-12-01T14:25:35+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/clinical-evaluations/</loc>
<lastmod>2011-12-01T14:35:59+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/shares/major-shareholders/</loc>
<lastmod>2011-10-18T17:08:42+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/mobile-lab/</loc>
<lastmod>2011-12-01T14:36:44+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/living-skin-equivalents/</loc>
<lastmod>2011-10-24T14:35:30+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/technologies/randd-pipeline/</loc>
<lastmod>2011-10-14T15:49:49+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/technologies/skin-care/</loc>
<lastmod>2011-10-24T14:38:27+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/technologies/active-database/</loc>
<lastmod>2011-10-24T14:42:08+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/living-skin-equivalents/background-technology/</loc>
<lastmod>2011-10-17T16:42:33+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/reports/annual/</loc>
<lastmod>2011-12-15T10:17:54+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/news-archive/</loc>
<lastmod>2012-01-05T15:47:23+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/services/living-skin-equivalents/applications-testing/</loc>
<lastmod>2011-12-01T14:32:14+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/reports/interim/</loc>
<lastmod>2011-10-12T12:17:17+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/press-kit/</loc>
<lastmod>2011-10-24T15:05:06+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/email-alerts/</loc>
<lastmod>2011-10-20T16:08:47+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/blog/</loc>
<lastmod>2011-10-20T10:43:32+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/publications/</loc>
<lastmod>2011-10-20T11:38:10+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/investment-overview/</loc>
<lastmod>2011-10-13T15:10:42+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/corporate-governance/board-committees/</loc>
<lastmod>2011-10-19T22:41:42+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/shares/</loc>
<lastmod>2011-10-25T17:17:06+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/business-development/licensing/</loc>
<lastmod>2011-10-20T15:31:37+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/corporate-governance/advisors/</loc>
<lastmod>2011-10-09T16:42:16+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/financial-calendar/</loc>
<lastmod>2011-12-14T12:32:56+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/company/business-development/history/</loc>
<lastmod>2011-10-14T15:23:51+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/corporate-governance/compliance/</loc>
<lastmod>2011-10-24T15:13:06+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/reports/</loc>
<lastmod>2011-10-25T17:19:19+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/corporate-governance/</loc>
<lastmod>2011-10-21T12:55:40+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/investors/investor-downloads/</loc>
<lastmod>2011-12-15T10:27:54+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/publications/financial-reports/</loc>
<lastmod>2011-10-19T22:27:34+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/downloads/services/</loc>
<lastmod>2011-12-20T12:22:51+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/news/publications/journals/</loc>
<lastmod>2011-10-10T16:49:57+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/downloads/technologies/</loc>
<lastmod>2011-10-20T10:10:04+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/downloads/investors/</loc>
<lastmod>2011-10-14T17:40:58+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


<url>
<loc>http://www.evocutis.com/contact/feedback/</loc>
<lastmod>2011-10-19T11:51:12+00:00</lastmod>
<priority>0.5</priority>
<changefreq>weekly</changefreq>
</url>


</urlset>
